Detalhe da pesquisa
1.
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 22(1): 72-80.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442316
2.
MAFLD predicts cardiovascular disease risk better than MASLD.
Liver Int
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641962
3.
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt.
J Viral Hepat
; 29(1): 87-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34582608
4.
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
J Viral Hepat
; 29(9): 807-816, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657138
5.
Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.
Hepatol Res
; 52(2): 165-175, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767312
6.
Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals.
J Hepatol
; 74(2): 303-311, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931878
7.
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation score.
Liver Int
; 41(11): 2768-2776, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174150
8.
Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt.
BMC Public Health
; 21(1): 1188, 2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158006
9.
An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
J Hepatol
; 72(4): 658-669, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734097
10.
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
J Hepatol
; 73(1): 202-209, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32278004
11.
A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.
J Viral Hepat
; 27(6): 593-601, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999866
12.
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study.
J Viral Hepat
; 27(7): 671-679, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32050037
13.
GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals.
Liver Int
; 40(11): 2828-2833, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946647
14.
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
Gut
; 68(4): 721-728, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666174
15.
Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.
J Hepatol
; 71(1): 62-70, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797050
16.
Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.
J Hepatol
; 80(5): e194-e197, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342440
17.
Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
Am J Gastroenterol
; 114(6): 929-937, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021832
18.
Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study.
J Med Virol
; 90(11): 1739-1744, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29900553
19.
Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness?
Ann Hepatol
; 17(5): 795-801, 2018 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145567
20.
MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma.
J Hepatol
; 77(6): 1717-1719, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055431